C-Type Natriuretic Peptide Engrafted Antibodies


Ontology type: sgo:Patent     


Patent Info

DATE

2019-10-16T00:00

AUTHORS

BROCKSCHNIEDER DAMIAN , HUDSON LUCAS , NOACK CLAUDIA , TEBBE JAN , WALSH STUART , WILMEN ANDREAS , WUNDER FRANK

ABSTRACT

The present invention relates to an antibody or a fragment thereof comprising at least one heterologous amino acid sequence incorporated within at least one CDR region of said antibody or fragment thereof, wherein said at least one heterologous amino acid sequence comprises an N-terminal linker sequence (Ntls), a C-Type Natriuretic Peptide (CNP) and a C-terminal linker sequence (Ctls). Optionally, at least a portion of said at least one CDR region is replaced by said at least one heterologous amino acid sequence incorporated therein. The present invention further relates to such antibody or fragment thereof for use in a method for treatment, a composition comprising such antibody or fragment thereof, a nucleic acid or a mixture of nucleic acids encoding such antibody or fragment thereof, a host cell comprising such nucleic acid or such mixture of nucleic acids and to a process for producing such antibody or fragment thereof. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "BROCKSCHNIEDER DAMIAN", 
        "type": "Person"
      }, 
      {
        "name": "HUDSON LUCAS", 
        "type": "Person"
      }, 
      {
        "name": "NOACK CLAUDIA", 
        "type": "Person"
      }, 
      {
        "name": "TEBBE JAN", 
        "type": "Person"
      }, 
      {
        "name": "WALSH STUART", 
        "type": "Person"
      }, 
      {
        "name": "WILMEN ANDREAS", 
        "type": "Person"
      }, 
      {
        "name": "WUNDER FRANK", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11897-010-0016-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022530445", 
          "https://doi.org/10.1007/s11897-010-0016-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-10-16T00:00", 
    "description": "

The present invention relates to an antibody or a fragment thereof comprising at least one heterologous amino acid sequence incorporated within at least one CDR region of said antibody or fragment thereof, wherein said at least one heterologous amino acid sequence comprises an N-terminal linker sequence (Ntls), a C-Type Natriuretic Peptide (CNP) and a C-terminal linker sequence (Ctls). Optionally, at least a portion of said at least one CDR region is replaced by said at least one heterologous amino acid sequence incorporated therein. The present invention further relates to such antibody or fragment thereof for use in a method for treatment, a composition comprising such antibody or fragment thereof, a nucleic acid or a mixture of nucleic acids encoding such antibody or fragment thereof, a host cell comprising such nucleic acid or such mixture of nucleic acids and to a process for producing such antibody or fragment thereof.

", "id": "sg:patent.EP-3553079-A1", "name": "C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.420044.6", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/EP-3553079-A1" ], "sdDataset": "patents", "sdDatePublished": "2022-10-01T07:03", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/patent/patent_29.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.EP-3553079-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.EP-3553079-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.EP-3553079-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.EP-3553079-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

53 TRIPLES      14 PREDICATES      16 URIs      8 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.EP-3553079-A1 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N10a1ce3af11641b7a74df69cb0b3ce41
4 schema:citation sg:pub.10.1007/s11897-010-0016-6
5 schema:datePublished 2019-10-16T00:00
6 schema:description <p id="pa01" num="0001">The present invention relates to an antibody or a fragment thereof comprising at least one heterologous amino acid sequence incorporated within at least one CDR region of said antibody or fragment thereof, wherein said at least one heterologous amino acid sequence comprises an N-terminal linker sequence (Ntls), a C-Type Natriuretic Peptide (CNP) and a C-terminal linker sequence (Ctls). Optionally, at least a portion of said at least one CDR region is replaced by said at least one heterologous amino acid sequence incorporated therein. The present invention further relates to such antibody or fragment thereof for use in a method for treatment, a composition comprising such antibody or fragment thereof, a nucleic acid or a mixture of nucleic acids encoding such antibody or fragment thereof, a host cell comprising such nucleic acid or such mixture of nucleic acids and to a process for producing such antibody or fragment thereof.</p>
7 schema:name C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES
8 schema:recipient grid-institutes:grid.420044.6
9 schema:sameAs https://app.dimensions.ai/details/patent/EP-3553079-A1
10 schema:sdDatePublished 2022-10-01T07:03
11 schema:sdLicense https://scigraph.springernature.com/explorer/license/
12 schema:sdPublisher N68569a3463e74a15b44da8e0546ecc3e
13 sgo:license sg:explorer/license/
14 sgo:sdDataset patents
15 rdf:type sgo:Patent
16 N0053d31566384b3b9d2b9be474c9cbc1 schema:name HUDSON LUCAS
17 rdf:type schema:Person
18 N05d973ec1a5d4b79848b343e91fcf632 rdf:first N61a9ea5866304bd189477c1037e72c56
19 rdf:rest N7fc083f4f474413eb7d8e609a57eef1c
20 N10a1ce3af11641b7a74df69cb0b3ce41 rdf:first N71f3b34351144ff499110f22794660a1
21 rdf:rest N6b43bbbe97ef4c25ac143651918168b3
22 N288d3fc96d7a4bee91dbaf1c7bcf1c15 rdf:first N3d8078df34334c6a97074181c61e8bba
23 rdf:rest Nd22e7a77594e41ff9ad96d9c161d5960
24 N2933b2fe2daa4df6a4861215f35b008f schema:name WUNDER FRANK
25 rdf:type schema:Person
26 N3d8078df34334c6a97074181c61e8bba schema:name WALSH STUART
27 rdf:type schema:Person
28 N61a9ea5866304bd189477c1037e72c56 schema:name NOACK CLAUDIA
29 rdf:type schema:Person
30 N68569a3463e74a15b44da8e0546ecc3e schema:name Springer Nature - SN SciGraph project
31 rdf:type schema:Organization
32 N6b43bbbe97ef4c25ac143651918168b3 rdf:first N0053d31566384b3b9d2b9be474c9cbc1
33 rdf:rest N05d973ec1a5d4b79848b343e91fcf632
34 N71f3b34351144ff499110f22794660a1 schema:name BROCKSCHNIEDER DAMIAN
35 rdf:type schema:Person
36 N7fc083f4f474413eb7d8e609a57eef1c rdf:first Nf7ece0093f7c49589968d72d714be8c2
37 rdf:rest N288d3fc96d7a4bee91dbaf1c7bcf1c15
38 Na0c2db150cf143b68843871871cfcd4a schema:name WILMEN ANDREAS
39 rdf:type schema:Person
40 Nc2dc7a8d401044fbbd73d0ddd59fc9e2 rdf:first N2933b2fe2daa4df6a4861215f35b008f
41 rdf:rest rdf:nil
42 Nd22e7a77594e41ff9ad96d9c161d5960 rdf:first Na0c2db150cf143b68843871871cfcd4a
43 rdf:rest Nc2dc7a8d401044fbbd73d0ddd59fc9e2
44 Nf7ece0093f7c49589968d72d714be8c2 schema:name TEBBE JAN
45 rdf:type schema:Person
46 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
47 rdf:type schema:DefinedTerm
48 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
49 rdf:type schema:DefinedTerm
50 sg:pub.10.1007/s11897-010-0016-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022530445
51 https://doi.org/10.1007/s11897-010-0016-6
52 rdf:type schema:CreativeWork
53 grid-institutes:grid.420044.6 schema:Organization
 




Preview window. Press ESC to close (or click here)


...